The application for the 12th annual event is open! Please fill out the information below for consideration.
The goal of the 12th Annual BIO Investor Forum is to bring together early and established private companies, as well as emerging public companies, with top private and public equity investors. A key programming element, Presentations allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience, fostering the development of important new medicines that will expand the industry’s pipeline.
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. Service providers will not be considered.
To submit an application, please complete the form below. You will receive an email regarding the status of your application in the coming weeks. For more information on company presentations, including registration and presentation fees, please click here.
Only the Company Description and Therapeutic Area of Focus may be used in conference materials. Other information below is used for selection purposes only and will not be printed in conference handbooks, or as profiles for the partnering system.